Dulan Lokuwithana

anusorn nakdee Plus Therapeutics ( PSTV ) shares rose in early premarket trading after its subsidiary CNSide Diagnostics announced an agreement with Elevance Health ( ELV ) to expand coverage for a cancer screening test.

Michail_Petrov-96 Kymera Therapeutics ( KYMR ) added ~10% in the premarket on Thursday after announcing an expedited timeline to share

Zerbor/iStock via Getty Images Nano-X Imaging ( NNOX ) lost ~24% in the premarket on Thursday after the Israeli MedTech reported

Tonix Pharmaceuticals (TNXP) stock and MapLight Therapeutics (MPLT) stock gains as Raymond James issues them new Strong Buy ratings. Read more here.

Healthcare dealmaking is already at the highest level since the pandemic, and the momentum is expected to continue into H2 2026, driven by looming

JHVEPhoto/iStock Editorial via Getty Images Amgen ( AMGN ) is facing a possible EU withdrawal of its rare-disorder therapy, Tavneos, after

Replimune ( REPL ) shares slipped in the premarket on Friday after the company announced that the FDA will convene an advisory committee to review

Shares of Omeros ( OMER ) fell ~25% in the premarket on Friday after an expert panel of the EU drug regulator, the European Medicines Agency, declined to endorse the company's transplant therapy narsoplimab.

Capricor Therapeutics ( CAPR ) lost ~12% on Friday after the U.S. FDA scheduled an advisory committee meeting to discuss the company's marketing application for Deramiocel, a treatment targeting Duchenne muscular dystrophy.

An expert panel of the EU drug regulator, the European Medicines Agency, endorsed six new medicines and 11 label expansions for approval this